Consumer and clinical wearables, remote monitoring, and digital health platforms.
Dexcom has announced that its Stelo continuous glucose monitor — the first OTC CGM approved by the FDA — has reached one million users, with the majority being people without diabetes who are using the device for metabolic health optimization.
